For years, contracting parties in California have thought they could avoid the uncertainty and expense of a jury trial by agreeing in advance that any lawsuit between them would be decided by a judge, sitting without a jury. This view was based in part on a 1991 intermediate appellate decision (Trizec Properties, inc. v. Superior Court) which upheld a pre-dispute contractual jury waiver, at least where the waiver was "clearly apparent in the contract." Last Friday, however, the California Supreme Court disapproved Trizec and held that California law does not permit pre-dispute jury waivers. See Grafton Partners, L.P. v PriceWaterHouseCoopers L.L.P., 05 C.D.O.S 6887 (August 5, 2005).
In Grafton, PriceWaterhouseCoopers (PWC) was hired to audit the books of two Grafton partnerships. PWC’s engagement letter provided that, in the event that differences concerning PWC’s services or fees could not be resolved by mutual agreement, the parties "agree not to demand a trial by jury in any action, proceeding or counterclaim arising out of or relating to [PWC’s] services and fees for this engagement."
Three years later, Grafton sued PWC for negligence and other claims arising from PWC’s alleged failure to disclose fraudulent business practices that had been discovered during an audit. The trial court struck Grafton’s demand for a jury trial, but the Court of Appeal reversed. The California Supreme Court unanimously upheld the Court of Appeal decision, holding that pre-dispute jury waivers are invalid. The Court also applied its decision retrospectively, i.e., to pending cases where a party seeks to rely on a predispute waiver.
The Court relied on California’s constitutional mandate that jury waivers in civil cases must be "as prescribed by statute." Looking to the applicable statute (Code of Civil Procedure § 631), the Court found that the Legislature has authorized waivers only in certain specific instances: by failing to appear at trial or announce that a jury was required, by oral consent in open court, by failing to pay jury fees, or by written consent filed with the court. All of these provisions, however, apply only to written jury waivers entered into after a lawsuit is filed.
The Court made clear that its decision does not prevent parties from agreeing in advance to arbitrate their disputes, reasoning that the Legislature had enacted a comprehensive scheme authorizing predispute arbitration agreements. Likewise, the Court ruled that parties are free to agree in advance to a "judicial reference," where a judicial referee is appointed to determine some or all of the issues in a case.
The Landscape after Grafton
Parties whose contracts include jury waivers should review those contracts and weigh the importance of avoiding a jury trial. If avoiding a jury is paramount, parties should consider revising their contracts to provide for arbitration or judicial reference.
The content of this article is intended to provide a general guide
to the subject matter. Specialist advice should be sought about your
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
In order to provide an overview for busy in-house counsel and compliance professionals, we summarize below some of the most important international anti-corruption developments in the past month with links to primary resources.
The lure of significant monetary awards continues to stimulate high-risk whistleblower actions under the False Claims Act, and these claims are increasingly common in the pharmaceutical and medical device industry.
Recent changes to the federal sentencing guidelines would lead to a number of major revisions to the law, including updates to the definition of "intended loss," the victims table and the meaning of "sophisticated means."
A recent $48.5 million False Claims Act (FCA) settlement between two laboratory companies and the federal government highlights the increased scrutiny of laboratory-physician compensation arrangements for potential Anti-Kickback Statute (AKS) violations.
On March 3, 2015, a court in the Southern District of Texas granted a defendant pharmaceutical company's motion for summary judgment on claims brought under the False Claims Act for alleged false claims...